Used in the development of antidiabetic agents due to its structural similarity to thiazolidinediones, a class of insulin sensitizers. It serves as a key intermediate in synthesizing compounds that target peroxisome proliferator-activated receptor gamma (PPARγ), helping regulate glucose metabolism and fatty acid storage. Its (Z)-configuration enhances binding affinity to PPARγ, improving efficacy in lowering blood glucose levels in preclinical studies. Also investigated for anti-inflammatory and antioxidant properties, supporting potential use in treating metabolic syndrome and type 2 diabetes complications.